N@N

BioElectronics Announces New Product Offerings and Enhancements to Target the Japanese Marketplace

^{Published on 2010-06-17 07:20:22 - Market Wire}
 

FREDERICK, MD--(Marketwire - June 17, 2010) - BioElectronics Corporation (PINKSHEETS: [ BIEL ]), the maker of inexpensive, disposable drug-free anti-inflammatory devices, and YesDTC Holdings (OTCBB: [ YESD ]), BioElectronics' exclusive distributor in Japan, today announced several important product line enhancements specifically tailored to suit the needs of the highly discerning and quality-conscious Japanese marketplace. These enhancements include requested modifications to the Allay™ Menstrual Pain Therapy and ActiPatch™ brands of products. Additionally, upon release, BioElectronics will make the recently announced back pain belt available first to the Japanese marketplace.

"We are very excited about our prospects within the Japanese market as both its medical practitioners and consumers are typically highly accepting of new treatment therapies. This, combined with the robustness of the economy and the favorable regulatory climate, leads us to believe Japan could easily be one of the most robust markets for our drug-free, anti-inflammatory and pain relieving technologies," commented Georgianna Golematis, Allay Brand Manager at BioElectronics. "We are excited to begin offering these product enhancements and to soon offer this new product to the Japanese marketplace."

Enhancements to the Allay product line will include a significantly improved on/off switch that will allow women to easily preserve battery life to enable use of the product for at least 10 menstrual cycles. Additionally, based on feedback from BioElectronics' Japanese distribution partners, several other important hygienic and aesthetic features of the product are being modified to better fit the Japanese marketplace. The ActiPatch product will also see modifications, which will include the fitting of new and stronger, flexible and breathable fabrics to ensure better fit and comfort.

Management of BioElectronics recently announced a revolutionary back pain belt, specifically designed to offer a safer alternative therapy for the approximately 80% of adults who suffer from this ailment. Due to favorable Japanese regulatory environment, combined with the sheer size of the Japanese economy, BioElectronics has agreed with its Japanese distribution partner to use Japan as one of its test beds for not only these new devices, but also for the enhanced Allay and ActiPatch product offerings.

About BioElectronics Corporation
BioElectronics Corporation (PINKSHEETS: [ BIEL ])is the maker of safe, inexpensive, drug-free medical devices and patches that deliver pulsed electromagnetic energy to relieve pain and inflammation. The company's wafer thin patches contain an embedded microchip and battery that deliver pulsed electromagnetic energy, a clinically proven and widely accepted anti-inflammatory and pain relief therapy that heretofore has only been possible to obtain from large, facility-based equipment. BioElectronics markets and sells its current products under the brand names ActiPatch®, RecoveryRx™, Allay™ Menstrual Pain Therapy and HealFast™ Therapy for cats, dogs and horses. The company is headquartered in Frederick, MD. For more information, visit [ www.bielcorp.com ].

About YesDTC Holdings, Inc.
YesDTC Holdings, Inc. is a direct-to-consumer marketing company specializing in direct response television (DRTV), internet and retail marketing programs. The Company brings a unique set of skills to this market space. YesDTC combines both the creative talents and financial acumen in order to create a total package for direct-to-consumer marketing programs. More information on YesDTC Holding can be found at [ www.yesdtc.com ].